Search for: "Sandoz, Inc" Results 181 - 200 of 680
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
FDA preemption/preclusion after Pom Wonderful: still powerful for drugs
21 Sep 2020, 12:38 pm by Rebecca Tushnet
Sandoz, Inc., 2020 WL 5535026, No. 19-cv-00318-MR (W.D.N.C. [read post]
43(B)log - http://tushnet.blogspot.com/
Supreme Court Mandates Deference to District Court Factual Findings When Reviewing Claim Construction
20 Jan 2015, 2:29 pm by RatnerPrestia
Sandoz, Inc. [read post]
Intellectual Property Law Resources - http://ratnerprestia.com/blog/
Court to rule on patent appeals
31 Mar 2014, 8:10 am by Lyle Denniston
Sandoz, Inc., involving Teva’s patent protection for its wide-selling drug Copaxone, used to reduce the frequency of relapses of multiple sclerosis. [read post]
SCOTUSblog - http://www.scotusblog.com/
Eon Labs Pays U.S. $3.5 Million to Settle Medicaid False Claims Allegations in qui tam case brought by Nolan and Auerbach, P.A. Client
22 Feb 2010, 8:41 am by Nolan and Auerbach
Eon Labs is a subsidiary of Sandoz Inc., which is in turn a subsidiary of Novartis AG. [read post]
Qui Tam 101 - http://false-claims-act.net
Federal Circuit: A New Standard for Materiality
21 Oct 2008, 8:37 pm
Sandoz, Inc., a decision that is sure to set off a firestorm of commentary. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu/
Federal Circuit: A New Standard for Materiality
21 Oct 2008, 8:37 pm
Sandoz, Inc., a decision that is sure to set off a firestorm of commentary. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu/
Another Fentanyl Patch Recall
4 Jan 2009, 9:50 pm
DURAGESIC 50 mcg/hr (fentanyl transdermal system) patches and Sandoz Inc. 50 mcg/hr fentanyl transdermal system patches being recalled may have a cut along one side of the drug reservoir. [read post]
A Georgia Lawyer - http://ageorgialawyer.blogspot.com/
FTC Conditions Watson’s Proposed Acquisition of Actavis on Divestitures
19 Oct 2012, 6:13 pm by John W. Arden
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]
Trade Regulation Talk - http://traderegulation.blogspot.com/
Court rejects argument that, under the circumstances, lack of Paragraph IV certification means no act of infringement and no jurisdiction.
5 Mar 2012, 10:30 am by James L. Higgins
Sandoz, Inc., Civ. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Chief Judge Sleet issues findings of fact and conclusions of law invalidating patents
3 Apr 2012, 9:15 am by James L. Higgins
Watson Laboratories, Inc. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Wednesday round-up
26 Apr 2017, 4:17 am by Edith Roberts
Sandoz Inc. [read post]
SCOTUSblog - http://www.scotusblog.com/
Why did the Supreme Court take Teva v. Sandoz?
22 Apr 2014, 6:22 am by Lawrence B. Ebert
Sandoz, Inc. [read post]
IPBiz - http://ipbiz.blogspot.com/
Statements of Efficacy and Safety Material Claim Limitations
3 Sep 2019, 7:41 am by Antoinette F. Konski
Sandoz, Inc., (Fed. [read post]
Personalized Medicine Bulletin - https://www.foley.com/en/insights/blogs/personalized-medicine-bulletin
AstraZeneca Prevails in Seroquel ® Paragraph IV Litigation
8 Jul 2008, 4:25 am
By Sherri Oslick -- Late last week, Judge Pisano of the District Court of New Jersey granted summary judgment of no inequitable conduct in favor of AstraZeneca in its consolidated Paragraph IV litigation against Teva Pharmaceuticals and Sandoz, Inc. over AstraZeneca's antipsychotic drug Seroquel ®. [read post]
Patent Docs - http://www.patentdocs.org/
Bayer v. Sandoz: Upping the Relevant Market Pleading Requirements
30 Sep 2011, 2:32 pm by Justin Boley, Associate
Sandoz, Inc., No. 1:08-cv-08112 (S.D.N.Y. [read post]
Wexler Wallace Law Firm Blog - http://blog.wexlerwallace.com/
Taming the Mongrel: Aligning Appellate Review of Claim Construction with its Evidentiary Character in Teva v. Sandoz
30 Jun 2014, 9:59 am by Jason Rantanen
Sandoz. [read post]
Patently-O - http://patentlyo.com/patent
CAFC affirms D. Del. in Sanofi v. Watson related to generic Multaq®
11 Nov 2017, 11:00 am by Lawrence B. Ebert
Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Federal Circuit Issues Order Clarifying Status of Doctrine of Equivalents
5 Sep 2019, 9:59 pm by Patent Docs
Sandoz Inc. earlier this year, regarding the doctrine of equivalents, which the Court corrected yesterday on Amgen's petition for rehearing regarding the panel opinion. [read post]
Patent Docs - http://www.patentdocs.org/
"Supreme Court weighs generic drug dispute"
15 Oct 2014, 11:52 am
Sandoz, Inc., No. 13-854. [read post]
How Appealing - http://howappealing.law.com/
Access online today's rulings of the U.S. Supreme Court in argued cases
20 Jan 2015, 7:07 am
Sandoz, Inc., No. 13-854. [read post]
How Appealing - http://howappealing.abovethelaw.com